Why don't ophthalmic viscoelastic devices (OVDs) cause an increase in intraocular pressure (IOP) after minimally invasive glaucoma surgery (MIGS) canaloplasty in a patient with a history of glaucoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why OVDs Don't Cause IOP Rise After MIGS Canaloplasty

OVDs used during MIGS canaloplasty procedures typically do not cause sustained IOP elevation because the procedure itself creates enhanced aqueous outflow through Schlemm's canal and the trabecular meshwork, which allows for rapid clearance of the viscoelastic material from the anterior chamber.

Mechanism of OVD Clearance in Canaloplasty

Enhanced Outflow Pathway

  • Canaloplasty mechanically dilates Schlemm's canal 360 degrees, which immediately improves trabecular outflow facility and creates a direct pathway for aqueous humor (and residual OVD) to exit the eye 1
  • The procedure restores physiologic drainage through the conventional outflow pathway, allowing viscoelastic material to be cleared through the same route rather than accumulating in the anterior chamber 2
  • Unlike traditional glaucoma surgeries that may temporarily obstruct outflow, canaloplasty specifically opens the drainage system, facilitating OVD egress 1

Surgical Technique Considerations

  • Modern MIGS canaloplasty techniques (using VISCO360 or OMNI systems) involve clear corneal incisions and controlled OVD injection that is subsequently removed through the enhanced trabecular pathway 1
  • The viscoelastic serves its purpose during surgery to maintain space and protect tissues, but the newly patent canal system allows for its efficient removal 2

Clinical Evidence Supporting Lack of IOP Spike

Post-Canaloplasty IOP Outcomes

  • In a large retrospective study of 206 eyes, canaloplasty achieved significant IOP reduction from 21.8 to 15.6 mm Hg in eyes with baseline IOP >18 mm Hg, with no reported sustained OVD-related pressure spikes 1
  • The procedure maintained IOP control at 13.9 mm Hg in eyes with baseline IOP ≤18 mm Hg, demonstrating that the enhanced outflow prevents OVD retention 1
  • Long-term follow-up extending to 42 months showed sustained IOP reduction without delayed pressure elevations that would suggest retained viscoelastic 1

Contrast with Other Surgical Scenarios

When OVD Does Cause Problems

  • During glaucoma drainage device implantation, viscoelastic injection can cause dramatic IOP spikes because the outflow pathway is not immediately functional 3
  • In eyes without enhanced drainage (such as during routine cataract surgery in glaucoma patients), OVD retention can contribute to postoperative pressure elevation 4

The Canaloplasty Advantage

  • Canaloplasty achieves IOP-lowering effects comparable to trabeculectomy but with a much lower risk profile, specifically avoiding the complications associated with bleb-dependent filtration 2
  • The tissue-sparing nature of the procedure maintains anatomic integrity while creating functional drainage, unlike filtering procedures where OVD could interfere with bleb formation 1

Important Clinical Caveats

  • Immediate postoperative monitoring remains essential: While sustained OVD-related IOP elevation is uncommon after canaloplasty, surgeons should still check IOP within the first 24 hours to ensure proper drainage function 1
  • Complete OVD removal during surgery: Surgeons should still attempt thorough removal of viscoelastic at the conclusion of the procedure, as the enhanced outflow is meant to handle residual amounts, not large volumes 2
  • Patient-specific factors matter: Eyes with severe trabecular damage or very advanced glaucoma may have less capacity to clear OVD even after canaloplasty, though this is uncommon 1

The fundamental principle is that canaloplasty creates the solution to the problem—by opening the natural drainage pathway, it provides the mechanism for OVD clearance that would otherwise cause pressure elevation in a compromised outflow system.

Related Questions

What are the causes of acute angle-closure glaucoma (AACG)?
What is the treatment for vision problems caused by angular ceilings?
Can a patient with a history of glaucoma and previous canaloplasty (canal surgery) repeat the procedure after an intraocular pressure (IOP) rise?
Can you have glaucoma without experiencing eye pain?
What is the management and treatment for acute glaucoma diagnosis?
Is L5-S1 Transforaminal Lumbar Interbody Fusion (TLIF) medically necessary for a 32-year-old male with severe lumbar spinal stenosis, large disc protrusion, and significant degenerative instability at the L5-S1 level, who has stopped smoking and is experiencing severe left-sided low back pain, numbness, and tingling in bilateral legs and feet, despite taking Lyrica (pregabalin) with minimal relief and THC (tetrahydrocannabinol) with adequate relief?
What is the recommended medication regimen for a patient experiencing alcohol withdrawal, considering their overall health status and potential contraindications?
What are the red flags for a patient presenting with a corneal abrasion, particularly those with a history of contact lens wear, recent eye surgery, pre-existing eye conditions such as glaucoma or uveitis, or compromised immune systems due to conditions like diabetes?
Can mannitol be used to manage a patient with a 3mm epidural hematoma (EDH) and a 13mm subdural hematoma (SDH)?
What are the indications, administration, and potential side effects of Prevenar 20 (pneumococcal conjugate vaccine) in adults 65 years or older or those with immunocompromising conditions or chronic heart or lung disease?
Is intralesional injection of triamcinolone acetonide (corticosteroid) 10 milligrams medically necessary for a patient with Hypertrophic Scar and Melanocytic Nevi, Unspecified?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.